A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Please note that all translations are automatically generated. Click here for the English version.
3.4K Views
•
10:46 min
•
September 13th, 2022
DOI :
September 13th, 2022
•Rozdziały w tym wideo
0:05
Introduction
1:02
Binding Assay
4:10
Flow Cytometry and Data Analysis
8:58
Results: Flow Cytometric-Based Assay to Study the Binding of an Aptamer and Cancer Cells
9:55
Conclusion
Powiązane Filmy
15:17
Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
13.9K Views
07:36
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
5.2K Views
08:49
Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens
14.3K Views
08:02
Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
5.4K Views
13:59
High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
1.9K Views
13:19
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
2.4K Views
11:14
Primer-Free Aptamer Selection Using A Random DNA Library
24.6K Views
09:39
Assessing Specificity of Anticancer Drugs In Vitro
9.4K Views
12:23
In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
1.6K Views
05:21
Assessing Antibody-dependent, Cell-mediated Cytotoxicity in Cancer Cells using Antibody-Dependent Cell-Mediated Cytotoxicity Reporter Bioassay
225 Views
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone